Skip to main content
Gut logoLink to Gut
. 1981 Apr;22(4):319–322. doi: 10.1136/gut.22.4.319

Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.

R P Walt, I F Trotman, R Frost, P L Golding, T H Shepherd, J Rawlings, R H Hunt, D Colin-Jones, G J Milton-Thompson, J J Misiewicz
PMCID: PMC1419156  PMID: 6113192

Abstract

One hundred and three outpatients with endoscopically diagnosed duodenal ulcer were randomly allocated to treatment with either cimetidine 200 mg tds and 400 mg nocte, or ranitidine 150 mg bd for four weeks. The endoscopists were not aware of the treatment and took no part in the clinical management. On completion of treatment ulcers had healed in 43 of 51 (84%) patients given cimetidine and in 40 of 52 (77%) patients given ranitidine. There were no serious unwanted effects in either treatment group. The results show no significant difference between healing rates after four weeks of standard cimetidine therapy or ranitidine 150 mg bd.

Full text

PDF
322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bank S., Barbezat G. O., Novis B. H., Tim L. O., Odes H. S., Helman C., Narunsky L., Duys P. J., Marks I. N. Histamine H2-receptor antagonists in the treatment of duodenal ulcers. S Afr Med J. 1976 Oct 16;50(44):1781–1785. [PubMed] [Google Scholar]
  2. Berstad A., Kett K., Aadland E., Carlsen E., Frislid K., Saxhaug K., Kruse-Jensen A. Treatment of duodenal ulcer with ranitidine, a new histamine H2-receptor antagonist. Scand J Gastroenterol. 1980;15(5):637–639. doi: 10.3109/00365528009182228. [DOI] [PubMed] [Google Scholar]
  3. Binder H. J., Cocco A., Crossley R. J., Finkelstein W., Font R., Friedman G., Groarke J., Hughes W., Johnson A. F., McGuigan J. E. Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology. 1978 Feb;74(2 Pt 2):380–388. [PubMed] [Google Scholar]
  4. Daly M. J., Humphray J. M., Stables R. Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide. Gut. 1980 May;21(5):408–412. doi: 10.1136/gut.21.5.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hetzel D. J., Hansky P. J., Shearman D. J., Korman M. G., Hecker R., Taggart G. J., Jackson R., Gabb B. W. Cimetidine treatment of duodenal ulceration: short term clinical trial and maintenance study. Gastroenterology. 1978 Feb;74(2 Pt 2):389–392. [PubMed] [Google Scholar]
  6. Kett K., Aadland E., Berstad A. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine. Scand J Gastroenterol. 1980;15(2):249–251. doi: 10.3109/00365528009181464. [DOI] [PubMed] [Google Scholar]
  7. Konturek S. J., Obtulowicz W., Kwiecien N., Sito E., Mikos E., Oleksy J. Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients. Gut. 1980 Mar;21(3):181–186. doi: 10.1136/gut.21.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Peden N. R., Saunders J. H., Wormsley K. G. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist. Lancet. 1979 Mar 31;1(8118):690–692. doi: 10.1016/s0140-6736(79)91146-2. [DOI] [PubMed] [Google Scholar]
  9. Walt R. P., Male P. J., Rawlings J., Hunt R. H., Milton-Thompson G. J., Misiewicz J. J. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer. Gut. 1981 Jan;22(1):49–54. doi: 10.1136/gut.22.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES